Search

Your search keyword '"P. Poydenot"' showing total 26 results

Search Constraints

Start Over You searched for: Author "P. Poydenot" Remove constraint Author: "P. Poydenot"
26 results on '"P. Poydenot"'

Search Results

1. Pathways from nucleation to raindrops

2. Collision efficiency of droplets across diffusive, electrostatic and inertial regimes

3. At the crossroads of epidemiology and biology: bridging the gap between SARS-CoV-2 viral strain properties and epidemic wave characteristics

4. Turbulent dispersion of breath by the wind

5. Stress accumulation around ice in a temperature gradient

6. Risk assessment for long and short range airborne transmission of SARS-CoV-2, indoors and outdoors

7. Structure and magnetism of self-organized Ge(1-x)Mn(x) nano-columns

10. Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation

11. LB989 Validation of the EpiScreen™ drug screening platform: Identification and characterization of trichostatin A as a potent epidermal differentiation enhancer

12. LB815 Validation of EpiScreenTM as a predictive in vitro cell-based assay for screening dermatological drugs by high content approaches

13. MyoScreen, a High-Throughput Phenotypic Screening Platform Enabling Muscle Drug Discovery

14. L’information du patient avant examen neuroradiologique

15. High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes

16. Réorganisation des personnels non médicaux du DIM au CHRU de Nancy

17. Structural and magnetic properties of GeMn layers; High Curie temperature ferromagnetism induced by self organized GeMn nano-columns

18. Benthic fauna and bioturbation on the Mediterranean continental slope: Toulon Canyon

21. MBNL-dependent impaired development within the neuromuscular system in myotonic dystrophy type 1.

22. Pluripotent Stem Cell-Based Drug Screening Reveals Cardiac Glycosides as Modulators of Myotonic Dystrophy Type 1.

23. MyoScreen, a High-Throughput Phenotypic Screening Platform Enabling Muscle Drug Discovery.

24. Mitochondrial damage and cytoskeleton reorganization in human dermal fibroblasts exposed to artificial visible light similar to screen-emitted light.

25. Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation.

26. mTOR-dependent proliferation defect in human ES-derived neural stem cells affected by myotonic dystrophy type 1.

Catalog

Books, media, physical & digital resources